09 May Iluvien Gains Ground
Iluvien receives further European approval for the treatment of diabetic macular edema. It has yet to be approved in the U.S. Iluvien is an injected sustained release system....
Iluvien receives further European approval for the treatment of diabetic macular edema. It has yet to be approved in the U.S. Iluvien is an injected sustained release system....
Ozurdex has been approved for the treatment of macular swelling caused by retinal vascular problems. In my own practice, Ozurdex is becoming more useful. It signifies the beginning of a new era!...
Ophthalmic drug delivery is changing with sustained release technology. Icon Biosciences, Inc., announces their intent to test a new anti-inflammatory extended release eye product. ...
Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration....
Alimera Sciences announces positive results on Iluvien. Phase 2 clinical trial data is promising....
Intraocular drug delivery systems are just emerging and the timing couldn't better....